| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |